← All trials
NCT06583590
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2024
- Primary completion
- Aug 31, 2025
- Completion date
- Dec 1, 2025
- First posted
- Sep 4, 2024
- Last posted
- Sep 4, 2024
- Enrollment
- 32
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Aswan UniversityLead sponsor
- Aswan UniversitySponsor investigator
- Aswan UniversityCollaborator
- Cairo UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.